Steven Schellings

Steven Schellings is currently the Associate Director of Strategic Accounts at AbbVie, Inc., bringing over thirty years of experience in the biopharmaceutical industry. They lead a commercial team at ImmunoGen, focusing on developing antibody-drug conjugates for difficult-to-treat cancers. Steven has previously held pivotal roles at reputable companies including Bristol-Myers Squibb, Merck, and Novartis, where they successfully managed partnerships and launched innovative cancer therapies. They are pursuing a Bachelor's degree in Communications from California Polytechnic State University and a Master's degree in Public Administration and Policy from the Evans School at the University of Washington.